--Needham Raises Price Target on Vaxcyte to $122 From $110, Maintains Buy Rating

MT newswire2026/10/05 17:27

By:MT newswire

01:27 PM EDT, 10/05/2026 (MT Newswires) -- Price: 73.87, Change: +17.39, Percent Change: +30.79

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.